Echerd Margaret 4
4 · Vaxart, Inc. · Filed Jul 21, 2021
Insider Transaction Report
Form 4
Vaxart, Inc.VXRT
Echerd Margaret
VP, Corporate Controller, PAO
Transactions
- Exercise/Conversion
Common Stock
2021-07-19$5.17/sh+333$1,722→ 333 total - Exercise/Conversion
Stock Option (right to buy)
2021-07-19−333→ 3,000 totalExercise: $5.17Exp: 2028-05-24→ Common stock (333 underlying) - Sale
Common Stock
2021-07-19$8.00/sh−1,800$14,400→ 0 total - Exercise/Conversion
Common Stock
2021-07-19$0.77/sh+1,467$1,130→ 1,800 total - Exercise/Conversion
Stock Option (right to buy)
2021-07-19−1,467→ 32,287 totalExercise: $0.77Exp: 2029-06-11→ Common stock (1,467 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
- [F2]The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of April 9, 2018, and the remaining shares in 36 equal monthly installments thereafter.
- [F3]The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter.